EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Symptom burden and post-COVID-19 syndrome 24 months following SARS-CoV-2 infection: Longitudinal population-based study

Raphael S Peter, Lisamaria Sedelmaier, Alexandra Nieters, Stefan O Brockmann, Siri Göpel, Uta Merle, Jürgen M Steinacker, Hans-Georg Kräusslich, Dietrich Rothenbacher, Winfried V Kern, EPILOC Phase 3a Study Group

Journal of Infection · 2025-06 · 90 (6) · 106500

DOI: 10.1016/j.jinf.2025.106500 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Infection, 2025-06. Verfasst von Raphael S Peter und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany. Electronic address: raphael.peter@uni-ulm.de. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State of Baden-Wurttemberg Ministry for Science Research and Art.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To describe the symptom burden and associated impairment two years after SARS-CoV-2 index infection. METHODS: Participants of an earlier large population-based survey in Southwestern Germany (August-September 2021) were contacted again in November 2023. We calculated the prevalences of suspected PCS and specific symptom clusters at both time points and investigated factors for their resolution or emergence. RESULTS: A total of 6635 subjects (mean age 46.6 years, 60.9% females) participated in the follow-up. Between baseline and follow-up (median 8.7 and 23.9 months after infection) there were only small changes in the point prevalence of post-COVID-19 syndrome (PCS) (29.9% versus 31.2%) or defined symptom clusters such as fatigue (23.8% versus 22.0%), neurocognitive impairment (15.8% versus 17.3%), or chest symptoms (14.4% versus 13.7%). Probabilities of resolution were often similar to probabilities of emergence, e.g. fatigue symptoms resolved in 9.8% of participants but emerged in 8.0%. Consistent predictors for emerging symptom clusters were female sex, obesity and medical treatment of the acute infection. The six main symptom clusters together explained 45% (physical domain) and 29% (mental domain) of the variance in health-related quality of life (hrQoL). CONCLUSIONS: We found a remaining high symptom prevalence two years after SARS-CoV-2 infection, but symptoms present nine months after the index infection often resolved, which was associated with increasing hrQoL. Remarkably, a considerable portion of symptoms newly emerged, of which only a few could be attributed to reported SARS-CoV-2 reinfection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansFemaleMaleMiddle AgedLongitudinal StudiesGermanyAdultFatigueSARS-CoV-2PrevalencePost-Acute COVID-19 SyndromeAgedCost of IllnessSymptom Burden

Stichwörter der Autor:innen

Health-related quality of lifeLong COVIDPopulation-based cohortPost-COVID-19 syndromeSymptom persistence

Autor:innen und Institutionen

  • Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany. Electronic address: raphael.peter@uni-ulm.de.
  • Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.
  • Institute for Immunodeficiency, Medical Centre and Faculty of Medicine, Albert-Ludwigs-University, Freiburg, Germany.
  • Department of Health Protection, Infection Control and Epidemiology, Baden-Wuerttemberg Federal State Health Office, Ministry of Social Affairs, Health and Integration, Stuttgart, Germany.
  • Division of Infectious Diseases, Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.
  • Department of Internal Medicine IV, University Hospital Heidelberg, Heidelberg, Germany.

Förderung

  • State of Baden-Wurttemberg Ministry for Science Research and Art

Zitieren

APA

Peter, R. S., Sedelmaier, L., Nieters, A., Brockmann, S. O., Göpel, S., Merle, U., Steinacker, J. M., Kräusslich, H. G., Rothenbacher, D., Kern, W. V., & EPILOC Phase 3a Study Group (2025). Symptom burden and post-COVID-19 syndrome 24 months following SARS-CoV-2 infection: Longitudinal population-based study. Journal of Infection, 90(6), 106500. https://doi.org/10.1016/j.jinf.2025.106500

Vancouver

Peter RS, Sedelmaier L, Nieters A, Brockmann SO, Göpel S, Merle U, et al. Symptom burden and post-COVID-19 syndrome 24 months following SARS-CoV-2 infection: Longitudinal population-based study. Journal of Infection. 2025;90(6):106500. doi:10.1016/j.jinf.2025.106500

BibTeX
@article{Peter2025,
  author = {Peter, Raphael S and Sedelmaier, Lisamaria and Nieters, Alexandra and Brockmann, Stefan O and Göpel, Siri and Merle, Uta and Steinacker, Jürgen M and Kräusslich, Hans-Georg and Rothenbacher, Dietrich and Kern, Winfried V and EPILOC Phase 3a Study Group, EPILOC Phase 3a Study Group},
  title = {Symptom burden and post-COVID-19 syndrome 24 months following SARS-CoV-2 infection: Longitudinal population-based study},
  journal = {Journal of Infection},
  year = {2025},
  volume = {90},
  number = {6},
  pages = {106500},
  doi = {10.1016/j.jinf.2025.106500}
}
Kostenlos starten →